Cadaveric renal allograft at the time of implantation has the similar immunological features with the rejecting allograft

Transplantation. 2000 Oct 15;70(7):1080-5. doi: 10.1097/00007890-200010150-00015.

Abstract

Background: Compared to living donations, cadaveric transplants have a poorer outcome, and the immunologic status of renal tissues at the time of transplantation might influence the final outcome of the renal allograft.

Patients and methods: We used quantitative RT-PCR to evaluate the differential expression of cytokine genes from 37 implantation tissues [18 cadaveric tissues (CI), 19 specimens from living donors (LI)]. We compared them with 17 acutely rejecting allograft (AR).

Results: Acute rejection within 6 months after transplantation occurred 8 times in patients with cadaveric allograft, but the living-donor recipients experienced 4 episodes (P<0.05). Proinflammatory cytokines were co-expressed more frequently in CI than in LI. The levels of IFN-gamma, TNF-alpha and IL-10 mRNA were also higher in CI. We compared the profiles of several cytokine expressions of CI with those of AR. The messages for IL-6 were more abundant in the CI, IFN-gamma was more expressed in AR, and the other cytokine expression levels were similar in both types. However, when comparing LI and AR, all the cytokine messages except IL-6 were up-regulated in AR than in LI. In CI, the levels of cytokine gene expressions were similar despite various cold ischemic time except IL-10 that were elevated for those cases where the operation was done within 4 hr of nephrectomy.

Conclusions: The numbers and levels of gene transcription of inflammatory cytokines were higher in the tissues from a cadaver, and were not different from those of AR. This immunologic hostility at the time of implantation would contribute to the poorer outcome of cadaveric allograft.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Cadaver
  • Cytokines / genetics
  • Graft Rejection / immunology
  • Graft Rejection / pathology
  • Humans
  • Interferon-gamma / genetics
  • Interleukin-10 / genetics
  • Kidney Transplantation / immunology*
  • Living Donors
  • Time Factors
  • Tissue and Organ Procurement / standards
  • Transcription, Genetic
  • Treatment Outcome

Substances

  • Cytokines
  • Interleukin-10
  • Interferon-gamma